Survivors of Tuberculosis May Benefit From Better Linkage to Post-Treatment Care

Survivors of Tuberculosis May Benefit From Better Linkage to Post-Treatment Care

Publication date: Jan 22, 2025

The median treatment duration was 224 (IQR, 189-289) days, and 7% of the overall cohort did not complete treatment. Patients who died of HIV coinfection were younger overall (mean age, 49. 6 years) at the time of post-treatment mortality. The researchers noted similar post-treatment mortality rates between patients who completed treatment and those who did not (both 7%). Eligible study patients included those aged 18 years and older who had a bacteriologic or clinical diagnosis of pulmonary or extrapulmonary TB disease. The researchers performed survival analyses among the cohort to determine risk factors for post-treatment mortality. Patients who died before or during TB treatment were excluded.

Concepts Keywords
December Alcohol
Diabetes Born
Georgia Care
Hispanic Ci
Researchers Cohort
Coinfection
Comprehensive
Hiv
Hr
Mortality
Population
Post
Risk
Treatment
Years

Semantics

Type Source Name
disease MESH malignancy
disease MESH cardiovascular disease
disease MESH end-stage kidney disease
disease IDO history
disease MESH pulmonary disease
drug DRUGBANK Ethanol
disease MESH HIV coinfection
disease MESH Emerging Infectious Diseases
disease MESH infection
drug DRUGBANK Tropicamide
pathway KEGG Tuberculosis
disease MESH Tuberculosis

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *